3rd Circ. Says No Rehearing Or Fees In Thalidomide Suit
The Third Circuit on Friday refused to reconsider its decision ending the last of Hagens Berman Sobol Shapiro LLP's suits against GlaxoSmithKline LLC on behalf of patients with thalidomide-related birth defects,...To view the full article, register now.
Already a subscriber? Click here to view full article